Results 181 to 190 of about 169,796 (292)

5-HT 2A receptor inverse agonist attenuates morphine withdrawal syndrome and its aversiveness in rats. [PDF]

Behav Pharmacol
Tsai PH, Morales ER, Reed YY, Qamar H, Jones EF, Saji G, Ward CP, Burstein ES, Moreno GL, Malin DH.   +9 more
europepmc   +1 more source

Post-acute withdrawal syndrome (PAWS) after stopping antidepressants: a systematic review with meta-narrative synthesis. [PDF]

Epidemiol Psychiatr Sci
Rennwald A, Hengartner MP.
europepmc   +1 more source

What is the efficacy of Precedex compared to traditional benzodiazepine therapy in managing symptoms of alcohol withdrawal syndrome?

Tripdatabase
openalex   +1 more source

Alcohol withdrawal syndrome management: Is there anything new?

, 2019
Guillaume Airagnes, G. Ducoutumany, B. Laffy-Beaufils, Anne-Laurence Le Faou, Frédéric Limosin   +4 more
openalex   +2 more sources

Efficacy and safety of Qudu Huiyuan Pills in the treatment of opioid withdrawal syndrome: a randomized, double-blind, placebo-controlled clinical trial. [PDF]

Behav Pharmacol
Xu J, Bai J, Wang J, Jin Y, Chang W, Li L, Zou L.   +6 more
europepmc   +1 more source

Five‐year outcomes of pembrolizumab versus chemotherapy in Chinese patients with non‐small‐cell lung cancer and programmed cell death ligand 1 tumor proportion score ≥1%: KEYNOTE‐042 China study

International Journal of Cancer, EarlyView.
What's New? Global research has found that for people newly diagnosed with advanced non‐small cell lung cancer (NSCLC), the anti‐PD‐1 monoclonal antibody pembrolizumab on its own often leads to better results than traditional chemotherapy. The present report details long‐term findings of pembrolizumab therapy specifically among Chinese patients.
Yi‐Long Wu, Li Zhang, Yun Fan, JianYing Zhou, Li Zhang, Qing Zhou, Wei Li, ChengPing Hu, GongYan Chen, Xin Zhang, CaiCun Zhou, Carmen González Arenas, Zhenghong Chen, Wen Cheng Yu, Tony S. K. Mok   +14 more
wiley   +1 more source

Optimal Drug, Optimal Dose, or Both in the Pharmacological Treatment of Neonatal Opioid Withdrawal Syndrome? [PDF]

Clin Pharmacol Ther
Kraft WK.
europepmc   +1 more source

Novel Targets in Treatment of Alcohol Dependence Induced Withdrawal Syndrome: An Insight Review

Ajeet Pal Singh, Amar Pal Singh
openalex   +1 more source

Exploring Multitarget Interactions to Reduce Opiate Withdrawal Syndrome and Psychiatric Comorbidity

, 2013
Fabio Del Bello, Eleonora Diamanti, Mario Giannella, Valerio Mammoli, Laura Mattioli, Federica Titomanlio, Alessandro Piergentili, Wilma Quaglia, Marco Lanza, Chiara Sabatini, Gianfranco Caselli, Elena Poggesi, Maria Pigini   +12 more
openalex   +1 more source

Organ‐sparing strategies in patients with MSI/dMMR tumors including Lynch syndrome: Current state of the art and future perspectives for clinical decision‐making

International Journal of Cancer, EarlyView.
Abstract Deficiency in DNA mismatch repair (dMMR) is a common pathway of carcinogenesis across different tumor types and confers a characteristic microsatellite instability‐high (MSI‐H) molecular phenotype. The MSI‐H/dMMR phenotype may arise from an inherited pathogenic variant in the context of Lynch syndrome and is most frequently observed in ...
Martin Duval, Antoine Dardenne, Thomas Samaille, Leo Mas, Jérémie H. Lefèvre, Xavier Dray, Mathilde Wagner, Romain Cohen, Thierry André   +8 more
wiley   +1 more source